Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.HiFiBiO completes first cohort of phase 1 study of SARS-CoV-2 neutralising antibody
HiFiBiO completes first cohort of phase 1 study of SARS-CoV-2 neutralising antibody. (Credit: Daniel Roberts from Pixabay)
HiFiBiO completes first cohort of phase 1 study of SARS-CoV-2 neutralising antibody. (Credit: Daniel Roberts from Pixabay)